1. Treatment of HIV infection - progress in perspective;Corey, L.; Fleming, T.R.;NEngljMed,1992
2. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection: a doubleblind, placebo controlled trial;Fischl, M.A.; Richmann, D.D.; Hansen, N.; Collier, A.C.; Carey, J.T.; Para, M.F.;Ann Intern Med,1990
3. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer;Volberding, P.A.; Lagakos, S.W.; Koch, M.A.; Pettinelli, C.; Myers, M.W.; Booth, D.K.;than; cells per cubic millimeter,1990
4. A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection;Hamilton, J.D.; Hartigan, P.M.; Simberkoff, M.S.; Day, P.L.; Diamond, G.R.; Dickinson, G.M.;N Engi J Med,1992
5. The effects on survival of early treatment of human immunodeficiency virus infection;Graham, N.M.H.; Zeger, L.; Park, L.P.; Vermund, S.H.; Detels, R.; Rinaldo, C.R.;N EnglJ Med,1992